Abstract:Medline (MDLN.O) jumps 41% on its Nasdaq debut, sparking strong investor interest. Trade Medline shares easily with FXPro as the stock gains global attention.

Medline (MDLN.O) made a remarkable debut on the Nasdaq, soaring 41% on its first day of trading and setting the pace for what is being hailed as 2025s most successful IPO so far. The companys public market entry underscored strong investor demand for healthcare and industrial leaders, even as broader markets remain uncertain.
The IPO attracted significant attention from institutional and retail investors, driving early gains and solidifying Medlines position as a major player to watch in the year ahead. Analysts note that this performance signals renewed confidence in companies rooted in tangible fundamentals, rather than purely tech-driven valuations.
Founded over five decades ago, Medline is among the worlds leading suppliers of medical and surgical products. Its extensive catalog spans everything from everyday consumables to advanced healthcare equipment, supporting hospitals and clinics worldwide.

In an era dominated by tech IPOs, Medlines strong market reception reaffirms the enduring appeal of resilient, essential industries. Its robust business foundation and consistent demand from the healthcare sector provide a stable outlook for investors seeking long-term value.
FXPro now offers traders access to Medline shares, allowing participation in post-IPO movements as the stock finds equilibrium. Through FXPro, investors can:
FXPro continues to expand its share offerings, adding new listings and major IPOs as they go public. Medlines promising start makes it a compelling addition for traders looking to capitalize on the 2025 IPO wave.
CFDs and Spread Betting are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading these products. Please ensure you understand the risks before trading.
FXPro is a leading global broker known for its advanced trading platforms, competitive spreads, and access to a wide range of markets, including stocks, commodities, and major IPOs.


If you are looking for a new broker, you might have stumbled upon OtetMarkets (or Otet Markets). They are a relatively new face in the industry, having established themselves in 2023. With a modern website and promises of high leverage using top-tier software like MT5 and cTrader, they certainly look the part.

Is TigerWit a scam? Review of revoked licenses, unregulated status, MT4 claims, WikiFX complaints & trader withdrawal risks. Hundreds of traders are questioning whether TigerWit is safe in 2025.

JPMorgan Chase is exploring cryptocurrency trading services for institutional clients, signaling Wall Street’s deeper move into digital assets.

[Dec 2025, Dubai] Trade W announces its Official Global Trading Partnership with Wolverhampton Wanderers FC for the 2025/2026 Premier League season, marking a major milestone in the company’s long term brand expansion strategy.